EX-99.3 5 exh_993.htm EXHIBIT 99.3 EdgarFiling

Supplemental Information 1 Exhibit 99.3

 

Integer is one of the largest medical device outsource manufacturers in the world 18 mfg. sites & 10 R&D centers worldwide Strong cash flow conversion ~60% of sales under LTA ~ 700 patents 9,000+ associates Our vision is to enhance the lives of patients worldwide by being our customers’ partner of choice for innovative technologies and services Integer Snapshot % Sales by End Markets (1) Medical Sales (97%) Non - Medical (3%) Portable Medical & AS&O Beaverton, OR Ireland Minneapolis, MN Brooklyn Park , MN Montevideo, Uruguay New Ross, Galway, Clarence, NY Ireland Alden, NY Penang, Malaysia Chaska, MN Plymouth, MN Tijuana, Mexico Juarez, Mexico A Premier, Global Presence Netanya, Israel Wilmington, MA Raynham, MA Quakertown, PA Salem, VA Trenton, GA Dominican Republic Plano, TX Palm Harbor, FL 51% 39% Cardio & CRM & Vascular Neuromod 7% 3% 1 Electrochem . ( 1 ) End market sales based on 2022 Year to Date sales through 9/30/2022 as 2022E results are not yet available. Note: The preliminary financial results for the fourth quarter and full year ended December 31, 2022 are based on information available to management as of January 30, 2022 and are subject to potential further material changes upon completion of the Company’s standard year - end closing procedures. Based on midpoints of announced ranges.

 

Portable Medical Product Line Strategy Update Products Assembled • Rechargeable Battery Packs • Chargers & Docks • Power Supplies Market Dynamics • Many competitors • Limited technology differentiation / No IP • Requires scale for efficiency • Low margins Product Dynamics • Assembly driven manufacturing • High sourced material content • Long development cycles x Exiting ~$40 million of sales  Supporting customers through 2025+  Finalizing last time buys x Retaining $30 million of Heart Failure & Cochlear implants  Technology differentiation; higher growth  Move to CRMN Product line … active implantables x Creating value  Margin accretive • Price increases • Overhead reduction  Creates low - cost manufacturing capacity (Tijuana) to support growth Li - Ion Battery Packs Core Battery Pack Assemblies Markets Served • Heart Failure • Cochlear • Cardiac Assist Chargers & Docks • Emergency • Respiratory • Sleep Care $70 $71 $69 Sales $71 Exiting $40 million of sales over 4 years … margin accretive ($ in millions) Product Line Overview Dynamics Actions 3 2